Asthma, allergy and the risk of prostate cancer: results from the Montreal PROtEuS study. - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles Cancer Epidemiology Year : 2014

Asthma, allergy and the risk of prostate cancer: results from the Montreal PROtEuS study.

Abstract

The few previous studies examining the association between asthma or allergy and prostate cancer (PCa) risk were inconclusive. This study aimed to evaluate these associations, and to explore in details the possible influence of current versus former allergic condition, age at onset, time since onset, and duration of each allergic condition. Detailed information on self-reported asthma and allergy was collected in the context of a large population-based case-control study conducted in Montreal, Canada. Study subjects included 1936 cases, diagnosed between 2005 and 2009, and 1995 population controls. Unconditional multivariate logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) adjusting for age, ancestry and familial history of prostate cancer. The ORs were 1.11 (95% CI: 0.89-1.40) and 0.98 (95% CI: 0.84-1.14) for ever reporting of asthma and allergy, respectively. These ORs did not substantially vary according to status (former or current), age at onset, time since onset, and duration of each allergic condition. PCa screening was not associated with allergic diseases reporting. Overall, our findings are in line with the absence of an association between a history of asthma or allergy, and PCa risk.
No file

Dates and versions

pasteur-01137343 , version 1 (30-03-2015)

Identifiers

Cite

Deborah Weiss, Mariam El-Zein, Marie-Claude Rousseau, Hugues Richard, Pierre I Karakiewicz, et al.. Asthma, allergy and the risk of prostate cancer: results from the Montreal PROtEuS study.. Cancer Epidemiology, 2014, 38 (6), pp.695-9. ⟨10.1016/j.canep.2014.10.003⟩. ⟨pasteur-01137343⟩

Collections

RIIP INRS-IAF
43 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More